STELLARIS PHARMACEUTICALS ApS: Financial statements 2019
CVR: 34708215
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -70,772 and a net result of DKK -57,616 compared with DKK -112,692 the year before. Equity in the 2019 report amounted to DKK -276,835.
- Gross Profit
- DKK -70,772
- Profit/Loss
- DKK -57,616
- Equity
- DKK -276,835
- Total Assets
- DKK 67,543
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -71 t. | -58 t. | -277 t. | - |
| 2018 | - | -70 t. | -113 t. | -219 t. | 0 |
| 2017 | - | -45 t. | -78 t. | -107 t. | 0 |
| 2016 | - | - | -118 t. | -575 t. | - |
| 2015 | - | - | -127 t. | -457 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK -70,497, and the net result was DKK -112,692.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.